Consideration of ZOREDORON acid to an osteoporosis patient and the validity of the vitamin D medicine manufacturing use

Kamagaya General Hospital0 个研究点目标入组 100 人开始时间: 2017年6月19日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•I make the patient who fills all following standards the subject.
•1) Japanese Society for Bone and Mineral Research A nuclear power plant, based on the check standard of the osteoporosis (revise in fiscal year 2012), a nuclear power plant, the patient diagnosed as osteoporosis.
•2) the age of the time of the agreement merit, more than 20-year-old patient (I don't ask about the gender.)
•3) the patient who is after menopause since putting it for the lady
•4) the patient who could get documentary consent by free will of the back and the patient person himself which had the enough explanation in case of participation of this research

•The patient who conflicts in following one of them won't incorporate in this research.
•1) the patient who has treatment reki of osteoporosis before agreement acquisition
•2) patient with peptic ulcer
•3) patient with abnormality of severe blood
•4) patient with severe hepatopathy
•5) patient with severe kidney trouble (patient of a creatinine clearance 35mL/min sheep rise)
•6) patient with a severe heart malfunction
•7) patient with operating during dental disposal or infection in the active mouth
•8) the patient who has that in a dehydrating state (high fever, the high loose bowels and vomit, etc.)
•9) patient of a hypocalcemia
•10) patient with the medical history of the severe drug allergy
•11) patient with aspirin asthma or its medical history
•12) the female with during pregnancy or a pregnant possibility or lactating woman
•13) additionally the patient who judged that a study person in charge was unsuitable as a subject of research person

发起方